Changes in neuropeptide expression in mice infected with prions

Neurobiology of Aging

Volumn 28, Issue 5, 2007, Pages 748-765

  Diez, Margarita ^a   Groth, Darlene ^b   DeArmond, Stephen J ^b   Prusiner, Stanley B ^b,c   Hökfelt, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CCK; Dentate gyrus; Enkephalin; Galanin; Hippocampus; Immunohistochemistry; In situ hybridization; Knockout; Neuropeptide Y; Scrapie; Transgenic mice

Indexed keywords

ACETYLCHOLINESTERASE; CHOLECYSTOKININ; DYNORPHIN; ENKEPHALIN; NEUROPEPTIDE; NEUROPEPTIDE Y; PRION PROTEIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRANULE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INOCULATION; KNOCKOUT MOUSE; MALE; MOSSY FIBER; MOUSE; MOUSE STRAIN; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; MALE; MICE; MICE, KNOCKOUT; NEUROPEPTIDES; PRION DISEASES; PRIONS;

EID: 33847371629     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.02.017     Document Type: Article

References (112)

1. Adolfsson R., Gottfries C.G., Roos B.T., and Winblad B. Changes in brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatr 135 (1979) 216-223
2. Beringue V., Demoy M., Lasmezas C.I., Gouritin B., Weingarten C., Deslys J.P., et al. Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J Pathol 190 (2000) 495-502
3. Bolton D.C., Bendheim P.E., Marmorstein A.D., and Potempska A. Isolation and structural studies of the intact scrapie agent protein. Arch Biochem Biophys 258 (1987) 579-590
4. Bounhar Y., Zhang Y., Goodyer C.G., and LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem 276 (2001) 39145-39149
5. Brown D.A., and Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (1992) 533-544
6. Brown D.R. Prion protein-overexpressing cells show altered response to a neurotoxic prion protein peptide. J Neurosci Res 54 (1998) 331-340
7. Brown D.R., Clive C., and Haswell S.J. Antioxidant activity related to copper binding of native prion protein. J Neurochem 76 (2001) 69-76
8. Brown D.R., Herms J., and Kretzschmar H.A. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. NeuroReport 5 (1994) 2057-2060
9. Brown D.R., Schulz-Schaeffer W.J., Schmidt B., and Kretzschmar H.A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 146 (1997) 104-112
10. Brown D.R., Wong B.S., Hafiz F., Clive C., Haswell S.J., and Jones I.M. Normal prion protein has an activity like that of superoxide dismutase. Biochem J 344 (1999) 1-5
11. Bruce M.E., and Dickinson A.G. Biological evidence that scrapie agent has an independent genome. J Gen Virol 68 Pt 1 (1987) 79-89
12. Carlson G.A., Ebeling C., Yang S.L., Telling G., Torchia M., Groth D., et al. Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci USA 91 (1994) 5690-5694
13. Carlson G.A., Kingsbury D.T., Goodman P.A., Coleman S., Marshall S.T., DeArmond S., et al. Linkage of prion protein and scrapie incubation time genes. Cell 46 (1986) 503-511
14. Carlson G.A., Westaway D., DeArmond S.J., Peterson-Torchia M., and Prusiner S.B. Primary structure of prion protein may modify scrapie isolate properties. Proc Natl Acad Sci USA 86 (1989) 7475-7479
15. Chandler R.L. Encephalopatjy in mice produced by inoculation with scrapie brain material. Lancet 1 (1961) 1378
16. Chesebro B., Race R., Wehrly K., Nishio J., Bloom M., Lechner D., et al. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315 (1985) 331-333
17. Chiarini L.B., Freitas A.R., Zanata S.M., Brentani R.R., Martins V.R., and Linden R. Cellular prion protein transduces neuroprotective signals. Embo J 21 (2002) 3317-3326
18. Chiesa R., Drisaldi B., Quaglio E., Migheli A., Piccardo P., Ghetti B., et al. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc Natl Acad Sci USA 97 (2000) 5574-5579
19. Civelli O., Douglass J., Goldstein A., and Herbert E. Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci USA 82 (1985) 4291-4295
20. Colmers W.F. Modulation of synaptic transmission in hippocampus by neuropeptide Y: presynaptic actions. Ann NY Acad Sci 611 (1990) 206-218
21. Counts S.E., Perez S.E., Ginsberg S.D., De Lacalle S., and Mufson E.J. Galanin in Alzheimer disease. Mol Interv 3 (2003) 137-156
22. Cross A.J., Crow T.J., Perry E.K., Perry R.H., Blessed G., and Tomlinson B.E. Reduced dopamine-B-hydroxylase activity in Alzheimer's disease. Br Med J 282 (1981) 93-94
23. Cross A.J., Kimberlin R.H., Crow T.J., Johnson J.A., and Walker C.A. Neurotransmitter metabolites, enzymes and receptors in experimental scrapie. J Neurol Sci 70 (1985) 231-241
24. Dagerlind A., Friberg K., Bean A.J., and Hökfelt T. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 98 (1992) 39-49
25. DeArmond S.J., Mobley W.C., DeMott D.L., Barry R.A., Beckstead J.H., and Prusiner S.B. Changes in the localization of brain prion proteins during scrapie infection. Neurology 37 (1987) 1271-1280
26. DeArmond S.J., Sanchez H., Yehiely F., Qiu Y., Ninchak-Casey A., Daggett V., et al. Selective neuronal targeting in prion disease. Neuron 19 (1997) 1337-1348
27. Deschenes R.J., Lorenz L.J., Haun R.S., Roos B.A., Collier K.J., and Dixon J.E. Cloning and sequence analysis of cDNA encoding rat preprocholecystokinin. Proc Natl Acad Sci USA 81 (1984) 726-730
28. Dickinson A.G., and Fraser H. Scrapie:pathogenesis in inbred mice: an assesment of host control and response involving many strains of agent. In: Katz M., and Meuler V. (Eds). Slow virus infections of CNS (1977), Springer, Berlin, Heidelberg, New York 3-14
29. Dickinson A.G., and Meikle V.M. A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7. Genet Res 13 (1969) 213-225
30. Diez M., Danner S., Frey P., Sommer B., Staufenbiel M., Wiederhold K.H., et al. Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23). Neurobiol Dis 14 (2003) 579-594
31. Diez M., DeArmond S.J., Groth D., Prusiner S.B., and Hökfelt T. Decreased MK-801 binding in discrete hippocampal regions of prion-infected mice. Neurobiol Dis 8 (2001) 692-699
32. Diez M., Koistinaho J., DeArmond S.J., Camerino A.P., Groth D., Caytano J.C., et al. Abberrant induction of neuropeptide Y mRNA in hippocampus CA3 pyramidal neurones in scrapie-infected mice. NeuroReport 7 (1996) 1887-1892
33. Diez M., Koistinaho J., DeArmond S.J., Groth D., Prusiner J.B., and Hökfelt T. Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease. Proc Natl Acad Sci USA 94 (1997) 13267-13272
34. Diez M., Koistinaho J., Kahn K., Games D., and Hökfelt T. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein-initial observations. Neuroscience 100 (2000) 259-286
35. Dorandeu A., Wingertsmann L., Chretien F., Delisle M.B., Vital C., Parchi P., et al. Neuronal apoptosis in fatal familial insomnia. Brain Pathol 8 (1998) 531-537
36. Durand-Gorde J.M., Bert J., and Nieoullon A. Early changes in tyrosine hydroxylase and glutamate decarboxylase activity in the golden hamster striatum after intracerebral inoculation of the nigrostriatal system with scrapie agent (strain 263 K). Neurosci Lett 51 (1984) 37-42
37. Durand-Gorde J.M., Bert J., and Nieoullon A. Changes in tyrosine hydroxylase, glutamic acid decarboxylase and choline acetyltransferase after local microinoculation of scrapie agen into the nigrostriatal system of the golden hamster. Brain Res 341 (1985) 243-251
38. Endo T., Groth D., Prusiner S.B., and Kobata A. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28 (1989) 8380-8388
39. Ferrer I., Casas R., and Rivera R. Parvalbumin-immunoreactive cortical neurons in Creutzfeldt-Jakob disease. Ann Neurol 34 (1993) 864-866
40. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., et al. Neurotoxicity of a prion protein fragment. Nature 362 (1993) 543-546
41. Fournier J.G., Escaig-Haye F., and Grigoriev V. Ultrastructural localization of prion proteins: physiological and pathological implications. Microsc Res Tech 50 (2000) 76-88
42. Fredens K., Stengaard-Pedersen K., and Wallace M.N. Localization of cholecystokinin in the dentate commissural-associational system of the mouse and rat. Brain Res 401 (1987) 68-78
43. Freund T.F., and Buzsaki G. Interneurons of the hippocampus. Hippocampus 6 (1996) 347-470
44. Frey P. Cholecystokinin octapeptide (CCK 26-33), nonsulfated octapeptide and tetrapeptide (CCK 30-33) in rat brain: analysis by high pressure liquid chromatography (HPLC) and radioimmunoassay (RIA). Neurochem Int 5 (1983) 811-815
45. Gall C., Berry L.M., and Hodgson L.A. Cholecystokinin in the mouse hippocampus: localization in the mossy fiber and dentate commissural systems. Exp Brain Res 62 (1986) 431-437
46. Gall C., Lauterborn J., Isackson P., and White J. Seizures, neuropeptide regulation, and mRNA expression in the hippocampus. Prog Brain Res 83 (1990) 371-390
47. Giese A., Groschup M.H., Hess B., and Kretzschmar H.A. Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol 5 (1995) 213-221
48. Gray F., Chretien F., Adle-Biassette H., Dorandeu A., Ereau T., Delisle M.B., et al. Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 58 (1999) 321-328
49. Guentchev M., Groschup M.H., Kordek R., Liberski P.P., and Budka H. Severe, early and selective loss of a subpopulation of GABAergic inhibitory neurons in experimental transmissible spongiform encephalopathies. Brain Pathol 8 (1998) 615-623
50. Harmey J.H., Doyle D., Brown V., and Rogers M.S. The cellular isoform of the prion protein, PrPc, is associated with caveolae in mouse neuroblastoma (N2a) cells. Biochem Biophys Res Commun 210 (1995) 753-759
51. Herms J., Tings T., Gall S., Madlung A., Giese A., Siebert H., et al. Evidence of presynaptic location and function of the prion protein. J Neurosci 19 (1999) 8866-8875
52. Hökfelt T., Bartfai T., and Bloom F. Neuropeptides: opportunities for drug discovery. Lancet Neurol 2 (2003) 463-472
53. Hökfelt T., Zhang X., and Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci 17 (1994) 22-30
54. res in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. J Comp Path 124 (2001) 20-28
55. Johnston A.R., Fraser J.R., Jeffrey M., and MacLeod N. Alterations in potassium currents may trigger neurodegeneration in murine scrapie. Exp Neurol 151 (1998) 326-333
56. Johnston A.R., Fraser J.R., Jeffrey M., and MacLeod N. Synaptic plasticity in the CA1 area of the hippocampus of scrapie-infected mice. Neurobiol Dis 5 (1998) 188-195
57. Keshet G.I., Ovadia H., Taraboulos A., and Gabizon R. Scrapie-infected mice and PrP knockout mice share abnormal localization and activity of neuronal nitric oxide synthase. J Neurochem 72 (1999) 1224-1231
58. Kretzschmar H.A., Prusiner S.B., Stowring L.E., and DeArmond S.J. Scrapie prion proteins are synthesized in neurons. Am J Pathol 122 (1986) 1-5
59. Kurawski G.R., Benedik M.J., Kamb B.J., Abrams J.Z., Zurawski S.M., and Lee F.D. Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 232 (1986) 772-775
60. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., et al. Prions prevent neuronal cell-line death. Nature 400 (1999) 225-226
61. Larhammar D., Ericsson A., and Persson H. Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci USA 84 (1987) 2068-2072
62. Lazarini F., Deslys J.P., and Dormont D. Regulation of the glial fibrillary acidic protein, beta actin and prion protein mRNAs during brain development in mouse. Brain Res Mol Brain Res 10 (1991) 343-346
63. Lieberburg I. Developmental expression and regional distribution of the scrapie-associated protein mRNA in the rat central nervous system. Brain Res 417 (1987) 363-366
64. Lu P., Sturman J.A., and Bolton D.C. Altered GABA distribution in hamster brain is an early molecular consequence of infection by scrapie prions. Brain Res 681 (1995) 235-241
65. Lucassen P.J., Williams A., Chung W.C., and Fraser H. Detection of apoptosis in murine scrapie. Neurosci Lett 198 (1995) 185-188
66. Luhr K.M., Wallin R.P., Ljunggren H.G., Low P., Taraboulos A., and Kristensson K. Processing and degradation of exogenous prion protein by CD11c(+) myeloid dendritic cells in vitro. J Virol 76 (2002) 12259-12264
67. Macchi G., Rossi G., Abbamondi A.L., Giaccone G., Mancia D., Tagliavini F., et al. Diffuse thalamic degeneration in fatal familial insomnia. A morphometric study. Brain Res 771 (1997) 154-158
68. Mallucci G., Dickinson A., Linehan J., Klohn P.C., Brandner S., and Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302 (2003) 871-874
69. Mallucci G.R., Ratte S., Asante E.A., Linehan J., Gowland I., Jefferys J.G., et al. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. Embo J 21 (2002) 202-210
70. Manson J., West J.D., Thomson V., McBride P., Kaufman M.H., and Hope J. The prion protein gene: a role in mouse embryogenesis?. Development 115 (1992) 117-122
71. Markey K.A., Kondo S., Shenkman L., and Goldstein M. Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line. Mol Pharmacol 17 (1980) 79-85
72. Marsh D., Grassi J., Vigny M., and Massoulie J. An immunological study of rat acetylcholinesterase: comparison with acetylcholinesterases from other vertebrates. J Neurochem 43 (1984) 204-213
73. McKinley M.P., Bolton D.C., and Prusiner S.B. A protease-resistant protein is a structural component of the scrapie prion. Cell 35 (1983) 57-62
74. Meyer R.K., McKinley M.P., Bowman K.A., Braunfeld M.B., Barry R.A., and Prusiner S.B. Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci USA 83 (1986) 2310-2314
75. Milhavet O., McMahon H.E., Rachidi W., Nishida N., Katamine S., Mange A., et al. Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci USA 97 (2000) 13937-13942
76. Mobley W.C., Neve R.L., Prusiner S.B., and McKinley M.P. Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. Proc Natl Acad Sci USA 85 (1988) 9811-9815
77. Muchowski P.J., and Wacker J.L. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6 (2005) 11-22
78. Müller W.E., Ushijima H., Schroder H.C., Forrest J.M., Schatton W.F., Rytik P.G., et al. Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 246 (1993) 261-267
79. Oesch B., Westaway D., Walchli M., McKinley M.P., Kent S.B., Aebersold R., et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40 (1985) 735-746
80. Ovadia H., Rosenmann H., Shezen E., Halimi M., Ofran I., and Gabizon R. Effect of scrapie infection on the activity of neuronal nitric-oxide synthase in brain and neuroblastoma cells. J Biol Chem 271 (1996) 16856-16861
81. Palkovits M. Neuropeptide messenger plasticity in the CNS neurons following axotomy. Mol Neurobiol 10 (1995) 91-103
82. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90 (1993) 10962-10966
83. Paxinos G., and Franklin K.B.J. The mouse brain in stereotaxic coordinates (2001), Academic Press, London, UK
84. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., and Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2 (1978) 1457-1459
85. Perry E.K., Tomlinson B.E., Blessed G., Perry R.H., Cross A.J., and Crow T.J. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. J Neurol Sci 51 (1981) 279-287
86. Prusiner S.B., McKinley M.P., Bowman K.A., Bolton D.C., Bendheim P.E., Groth D.F., et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35 (1983) 349-358
87. Prusiner S.B., Scott M.R., DeArmond S.J., and Cohen F.E. Prion protein biology. Cell 93 (1998) 337-348
88. Sadowski M., Tang C.Y., Aguinaldo J.G., Carp R., Meeker H.C., and Wisniewski T. In vivo micro magnetic resonance imaging signal changes in scrapie infected mice. Neurosci Lett 345 (2003) 1-4
89. Sales N., Hassig R., Rodolfo K., Di Giamberardino L., Traiffort E., Ruat M., et al. Developmental expression of the cellular prion protein in elongating axons. Eur J Neurosci 15 (2002) 1163-1177
90. Sales N., Rodolfo K., Hassig R., Faucheux B., Di Giamberardino L., and Moya K.L. Cellular prion protein localization in rodent and primate brain. Eur J Neurosci 10 (1998) 2464-2471
91. Schultzberg M., Hökfelt T., Terenius L., Elfvin L.G., Lundberg J.M., Brandt J., et al. Enkephalin immunoreactive nerve fibres and cell bodies in sympathetic ganglia of the guinea-pig and rat. Neuroscience 4 (1979) 249-270
92. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M., and Vezzani A. Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res Rev 22 (1996) 27-50
93. Selkoe D.J. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 6 (2004) 1054-1061
94. Stahl N., Borchelt D.R., Hsiao K., and Prusiner S.B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51 (1987) 229-240
95. Taraboulos A., Scott M., Semenov A., Avrahami D., Laszlo L., Prusiner S.B., et al. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 129 (1995) 121-132 [published erratum appears in J Cell Biol 1995 Jul;130(2):501]
96. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79 (1982) 5485-5489
97. Tatzelt J., Groth D.F., Torchia M., Prusiner S.B., and DeArmond S.J. Kinetics of prion protein accumulation in the CNS of mice with experimental scrapie. J Neuropathol Exp Neurol 58 (1999) 1244-1249
98. Telling G.C., Haga T., Torchia M., Tremblay P., DeArmond S.J., and Prusiner S.B. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev 10 (1996) 1736-1750
99. Theodorsson E., and Rugarn O. Radioimmunoassay for rat galanin: immunochemical and chromatographic characterization of immunoreactivity in tissue extracts. Scand J Clin Lab Invest 60 (2000) 411-418
100. Thiriet N., Deng X., Solinas M., Ladenheim B., Curtis W., Goldberg S.R., et al. Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. Neurobiol Dis 25 (2005) 5279-5283
101. Tschampa H.J., Herms J.W., Schulz-Schaeffer W.J., Maruschak B., Windl O., Jastrow U., et al. Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology. Brain 125 (2002) 2558-2566
102. Vezzani A., Sperk G., and Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22 (1999) 25-30
103. Vrontakis M.E., Peden L.M., Duckworth M.L., and Friesen H.G. Isolation and characterization of a complementary DNA (galanin) clone from estrogen-induced pituitary tumor messenger RNA. J Biol Chem 262 (1987) 16755-16758
104. Weber E., Evans C.J., and Barchas J.D. Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions. Nature 299 (1982) 77-79
105. Westaway D., Cooper C., Turner S., Da Costa M., Carlson G.A., and Prusiner S.B. Structure and polymorphism of the mouse prion protein gene. Proc Natl Acad Sci USA 91 (1994) 6418-6422
106. Westaway D., Goodman P.A., Mirenda C.A., McKinley M.P., Carlson G.A., and Prusiner S.B. Distinct prion proteins in short and long scrapie incubation period mice. Cell 51 (1987) 651-662
107. White A.R., Collins S.J., Maher F., Jobling M.F., Stewart L.R., Thyer J.M., et al. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol 155 (1999) 1723-1730
108. Williams A., Lucassen P.J., Ritchie D., and Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 144 (1997) 433-438
109. Wynick D., and Bacon A. Targeted disruption of galanin: new insights from knock-out studies. Neuropeptides 36 (2002) 132-144
110. Wynick D., Thompson S.W., and McMahon S.B. The role of galanin as a multi-functional neuropeptide in the nervous system. Curr Opin Pharmacol 1 (2001) 73-77
111. Zanata S.M., Lopes M.H., Mercadante A.F., Hajj G.N., Chiarini L.B., Nomizo R., et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. Embo J 21 (2002) 3307-3316
112. Zlotnik I. Observations on the experimental transmission of scrapie of various origins to laboratory animals. Slow, latent, and temperature virus infections. NINDB Monogr (1965) 237-248